I'm aware.
Including using Dogs.
My point was that a Phase 1 trial costs twice as much as you have in the bank.
How are you going to fund it without a CR or JV.
This ain't downramping - it's a question y'all should be asking the board about asap.
Nyrada does have potential.
I agree.
I just don't see how they move forward and stay intact as a company.
Ann: Brain Injury Program GLP Studies Further Update, page-5
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.028(32.2%) |
Mkt cap ! $17.85M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 11.5¢ | 8.8¢ | $190.9K | 1.906M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 118530 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 203490 | 4 |
View Market Depth
| Last trade - 12.00pm 03/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |